Status:
UNKNOWN
4-10 Week Observational Study Comparing 3 Management Strategies for Obstructive Chronic BronchoPneumopathy (OCBP) in Common Clinical Practice
Lead Sponsor:
Hospices Civils de Lyon
Collaborating Sponsors:
Novartis
Conditions:
Obstructive Chronic BronchoPneumopathy (OCBP)
Eligibility:
All Genders
40-75 years
Brief Summary
The management of patients with Obstructive Chronic BronchoPneumopathy (OCBP) is based on a progression of therapeutic options and on a sensitization to physical activity. For these patients selected...
Eligibility Criteria
Inclusion
- Patients with Obstructive Chronic BronchoPneumopathy stage ≥ 2.
- Patients under treatment with LABA or LAMA or LABA+LAMA since at least 1 month.
- VEMS/CVF\<70%
- VEMS\<80%
- Patients without regular physical activity and without physical activity program since 1 year.
Exclusion
- Patients under treatment with LABA + inhaled Corticoids.
- Contraindication to physical activity.
- Patients with previous history of respiratory exacerbations.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01885247
Start Date
June 1 2013
End Date
December 1 2016
Last Update
May 10 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon
Lyon, France, 69004